Low Incidence of Anti-Osteoporosis Treatment After Hip Fracture

2008153 citationsJournal Articlegreen Open Access

Authors

Véronique Rabenda · University of Liège

Johan Vanoverloop · Landsbond der Christelijke Mutualiteiten (Belgium)

Valérie Fabri · Landsbond der Christelijke Mutualiteiten (Belgium)

Raf Mertens · Landsbond der Christelijke Mutualiteiten (Belgium)

F. Sumkay · Landsbond der Christelijke Mutualiteiten (Belgium)

Carine Vannecke · Rijksinstituut voor Ziekte- en Invaliditeitsverzekering

Abstract

The vast majority of patients who experience a hip fracture do not take anti-osteoporotic therapy after the fracture. Furthermore, among patients who begin alendronate treatment after the fracture, the adherence to treatment decreases over time and remains suboptimal.

Topics & Keywords

Bone health and osteoporosis research Bone health and treatments Hip and Femur Fractures

Publication Details

Published in: Journal of Bone and Joint Surgery

Volume 90, Issue 10, pp. 2142-2148

DOI: 10.2106/jbjs.g.00864

Field-Weighted Citation Impact: 9.42

Command Palette

Low Incidence of Anti-Osteoporosis Treatment After Hip Fracture

Authors

Abstract

Topics & Keywords

Publication Details